Literature DB >> 10377456

Activation of erythropoietin receptor in the absence of hormone by a peptide that binds to a domain different from the hormone binding site.

T Naranda1, K Wong, R I Kaufman, A Goldstein, L Olsson.   

Abstract

Applying a homology search method previously described, we identified a sequence in the extracellular dimerization site of the erythropoietin receptor, distant from the hormone binding site. A peptide identical to that sequence was synthesized. Remarkably, it activated receptor signaling in the absence of erythropoietin. Neither the peptide nor the hormone altered the affinity of the other for the receptor; thus, the peptide does not bind to the hormone binding site. The combined activation of signal transduction by hormone and peptide was strongly synergistic. In mice, the peptide acted like the hormone, protecting against the decrease in hematocrit caused by carboplatin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10377456      PMCID: PMC22127          DOI: 10.1073/pnas.96.13.7569

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  A partial model of the erythropoietin receptor complex.

Authors:  J A Caravella; P D Lyne; W G Richards
Journal:  Proteins       Date:  1996-03

2.  Regulation of insulin receptor functions by a peptide derived from a major histocompatibility complex class I antigen.

Authors:  J Stagsted; G M Reaven; T Hansen; A Goldstein; L Olsson
Journal:  Cell       Date:  1990-07-27       Impact factor: 41.582

3.  A peptide derived from an extracellular domain selectively inhibits receptor internalization: target sequences on insulin and insulin-like growth factor 1 receptors.

Authors:  T Naranda; A Goldstein; L Olsson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

4.  Regulation of receptor internalization by the major histocompatibility complex class I molecule.

Authors:  L Olsson; A Goldstein; J Stagsted
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

5.  Beta-sheet models for the ordered filamentous structure formed by a peptide that enhances the action of insulin.

Authors:  L Weaver; J Stagsted; O Behnke; B W Matthews; L Olsson
Journal:  J Struct Biol       Date:  1996 Nov-Dec       Impact factor: 2.867

6.  Homodimerization of erythropoietin receptor by a bivalent monoclonal antibody triggers cell proliferation and differentiation of erythroid precursors.

Authors:  H Schneider; W Chaovapong; D J Matthews; C Karkaria; R T Cass; H Zhan; M Boyle; T Lorenzini; S G Elliott; L B Giebel
Journal:  Blood       Date:  1997-01-15       Impact factor: 22.113

7.  Small peptides as potent mimetics of the protein hormone erythropoietin.

Authors:  N C Wrighton; F X Farrell; R Chang; A K Kashyap; F P Barbone; L S Mulcahy; D L Johnson; R W Barrett; L K Jolliffe; W J Dower
Journal:  Science       Date:  1996-07-26       Impact factor: 47.728

8.  Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A.

Authors:  O Livnah; E A Stura; D L Johnson; S A Middleton; L S Mulcahy; N C Wrighton; W J Dower; L K Jolliffe; I A Wilson
Journal:  Science       Date:  1996-07-26       Impact factor: 47.728

9.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex.

Authors:  A M de Vos; M Ultsch; A A Kossiakoff
Journal:  Science       Date:  1992-01-17       Impact factor: 47.728

10.  T lymphocyte costimulation mediated by reorganization of membrane microdomains.

Authors:  A Viola; S Schroeder; Y Sakakibara; A Lanzavecchia
Journal:  Science       Date:  1999-01-29       Impact factor: 47.728

View more
  5 in total

Review 1.  Drugs for increasing oxygen and their potential use in doping: a review.

Authors:  Aurelie Gaudard; Emmanuelle Varlet-Marie; Francoise Bressolle; Michel Audran
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

2.  Small-molecule agonists for the glucagon-like peptide 1 receptor.

Authors:  Lotte Bjerre Knudsen; Dan Kiel; Min Teng; Carsten Behrens; Dilip Bhumralkar; János T Kodra; Jens J Holst; Claus B Jeppesen; Michael D Johnson; Johannes Cornelis de Jong; Anker Steen Jorgensen; Tim Kercher; Jarek Kostrowicki; Peter Madsen; Preben H Olesen; Jacob S Petersen; Fritz Poulsen; Ulla G Sidelmann; Jeppe Sturis; Larry Truesdale; John May; Jesper Lau
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-09       Impact factor: 11.205

Review 3.  Structural and functional hot spots in cytokine receptors.

Authors:  C J Bagley; J M Woodcock; M A Guthridge; F C Stomski; A F Lopez
Journal:  Int J Hematol       Date:  2001-04       Impact factor: 2.490

4.  Discovery and Characterization of Nonpeptidyl Agonists of the Tissue-Protective Erythropoietin Receptor.

Authors:  James L Miller; Timothy J Church; Dmitri Leonoudakis; Karen Lariosa-Willingham; Normand L Frigon; Connie S Tettenborn; Jeffrey R Spencer; Juha Punnonen
Journal:  Mol Pharmacol       Date:  2015-05-27       Impact factor: 4.436

5.  Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia.

Authors:  Y Wang; Z G Zhang; K Rhodes; M Renzi; R L Zhang; A Kapke; M Lu; C Pool; G Heavner; M Chopp
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.